Phosphoinositide 3-kinase in health and disease Volume 1 /
From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...
| Other Authors: | , , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Heidelberg :
Springer Verlag,
2010
|
| Series: | Current topics in microbiology and immunology ;
v. 346 |
| Subjects: |
Internet
This item is not available through BorrowDirect. Please contact your institution’s interlibrary loan office for further assistance.Stanford University
| Call Number: |
ISIL:US-CST |
|---|